Amgen makes all Repatha device options available in U.S. at 60% reduced price

Amgen announced that all Repatha device options, including the Pre-Filled Syringe and Pushtronex (on-body infusor with prefilled cartridge), are now available at a 60% reduced list price of $5,850 per year. The most commonly used delivery system, the Repatha SureClick autoinjector, was made available at the lower list price of $5,850 on Oct. 24, 2018. The lower priced Repatha options are identical to the Repatha options currently available, but have been introduced to reduce out-of-pocket costs for patients, especially Medicare patients.
https://thefly.com/landingPageNews.php?id=2844971